Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia

Title
Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
Authors
Keywords
Apolipoprotein, High-density lipoprotein, Low-density lipoprotein-cholesterol, Proprotein convertase subtilisin/kexin type 9, Triglycerides
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume 30, Issue 3, Pages 305-313
Publisher
Springer Nature
Online
2016-05-30
DOI
10.1007/s10557-016-6666-1

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started